Furthermore, the importance of RPN2 in tumor prognosis and therapeutic implications has been documented in other solid cancers, including esophageal squamous cell carcinoma [54, 55], osteosarcoma [56, 57] and breast cancer [50]. This evidence concerns the gene RPN2 and breast cancer.